Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangzhou Zhongbao Pharmaceutical is a Chinese pharmaceutical manufacturer based in Yangzhou, Jiangsu Province, specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a diverse portfolio of products, with a particular emphasis on injectable medications, including hormones, antibiotics, and cardiovascular drugs. Operating under strict Good Manufacturing Practice (GMP) standards, the firm supplies essential medicines such as dexamethasone and gentamicin to both domestic and international markets. Yangzhou Zhongbao focuses on high-quality generic drug production and has established a significant presence in the regional healthcare sector through its extensive manufacturing capabilities. The company's facilities are equipped for large-scale production of small molecule therapeutics across multiple delivery formats, contributing to the essential medicine supply chain in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzhou Zhongbao Pharmaceutical.